Health

Cuba approves clinical trial with Mambisa and Abdala in COVID-19 convalescents

July 14, 2021
Written by ACN
Category: Health
Hits: 969

The Cuban Center for State Control of Medicines, Equipment and Medical Devices approved the phase I/II clinical trial to evaluate the safety and immunogenicity of the vaccine candidate Mambisa -intranasal- and the Abdala vaccine -intramuscular-, a study to boost immunity in convalescents of COVID-19.

Efficacy of Soberana 02 and Soberana Plus three-dose scheme achieves 91.2%

July 9, 2021
Written by RHC
Category: Health
Hits: 1031

The efficacy of the Soberana 02 vaccine candidate in its three-dose schedule together with Soberana Plus is 91.2%, which exceeds the World Health Organization (WHO) requirements for a vaccine candidate against COVID-19 to become a vaccine, which is 50%.

US magazine praises Cuba´s Soberana 02 vaccine candidate

July 6, 2021
Written by Redacción ¡ahora!
Category: Health
Hits: 1003

Design, obtaining and preclinical assessment of Cuban anti-Covid Soberana 02 vaccine candidate reached the headlines of the US magazine ACS Chemical Biology, paving the way for other antiviral vaccines.

Umelisa SARS-COV-2 antigen, a 100 % Cuban diagnostic system

July 5, 2021
Written by RHC
Category: Health
Hits: 1250

The Immunoassay Center has developed a new product to diagnose the Sars-Cov-2 virus.

Cuba Declares Community Transmission Phase for COVID-19

June 30, 2021
Written by ACN
Category: Health
Hits: 874

Cuban Public Health Minister Jose Angel Portal Miranda informed that the country is now under the community transmission phase for COVID-19 given the high contagious impact by the virus and the increase of its incidence levels over the past 15 days, add to this the circulation of highly contagious variants of the SARS-CoV-2.

More Articles ...